— Know what they know.
Not Investment Advice

CVET NASDAQ

Covetrus, Inc.
1W: +0.4% 1M: +0.6% 3M: +1.3% 1Y: +13.3% 3Y: +85.4%
$20.99
Last traded 2022-10-12 — delisted
NASDAQ · Healthcare · Medical - Distribution

Revenue Segmentation

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$4.6B +5.4% ▲
5Y CAGR: +6.4%
Gross Profit
$858M +7.5% ▲
5Y CAGR: +6.7%
Operating Income
-$22M +68.1% ▲
Net Income
-$86M -352.6% ▼
EPS (Diluted)
$-0.63 -293.8% ▼
EBITDA
$179M -15.6% ▼
5Y CAGR: +3.1%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2017FY2018FY2019FY2020FY2021
Revenue$3.6B$3.8B$4.0B$4.3B$4.6B
YoY Growth+6.8%+5.5%+5.2%+9.1%+5.4%
Cost of Revenue$2.9B$3.1B$3.2B$3.5B$3.7B
Gross Profit$652M$684M$749M$798M$858M
Gross Margin18.2%18.1%18.8%18.4%18.8%
R&D Expenses$0$0$0$0$0
SG&A Expenses$517M$538M$808M$867M$881M
Operating Expenses$517M$538M$808M$867M$881M
Operating Income$135M$137M-$997M-$69M-$22M
Operating Margin3.8%3.6%-25.1%-1.6%-0.5%
Interest Expense$0$0$56M$47M$32M
Income Before Tax$139M$143M-$1.0B-$26M-$54M
Tax Expense$48M$37M-$7M-$7M$32M
Net Income$64M$101M-$1.0B-$19M-$86M
Net Margin1.8%2.7%-25.6%-0.4%-1.9%
EPS (Diluted)$0.58$0.91$-9.52$-0.16$-0.63
EBITDA$171M$202M-$794M$213M$179M
Shares Outstanding111M111M107M118M137M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms